BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 26637809)

  • 1. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
    Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
    Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
    Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
    Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/β-catenin pathway.
    Zhou G; Li C; Zhan Y; Zhang R; Lv B; Geng W; Zheng J
    Phytomedicine; 2020 Dec; 79():153321. PubMed ID: 32919323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
    Yu F; Fan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling.
    Hasan HF; Abdel-Rafei MK; Galal SM
    Biochem Cell Biol; 2017 Jun; 95(3):400-414. PubMed ID: 28177765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
    Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
    Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathway.
    Zheng J; Wu C; Xu Z; Xia P; Dong P; Chen B; Yu F
    Mol Cell Biochem; 2015 Jan; 398(1-2):1-9. PubMed ID: 25148875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.
    Yang Y; Chen XX; Li WX; Wu XQ; Huang C; Xie J; Zhao YX; Meng XM; Li J
    J Cell Mol Med; 2017 Oct; 21(10):2317-2328. PubMed ID: 28332284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
    Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
    J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation.
    Yu F; Lu Z; Chen B; Wu X; Dong P; Zheng J
    J Cell Mol Med; 2015 Nov; 19(11):2617-32. PubMed ID: 26257392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
    Tao YY; Wang QL; Shen L; Fu WW; Liu CH
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
    Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
    Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-708 represses hepatic stellate cells activation and proliferation by targeting ZEB1 through Wnt/β-catenin pathway.
    Yang J; Tao Q; Zhou Y; Chen Q; Li L; Hu S; Liu Y; Zhang Y; Shu J; Zhang X; Zhang L; Zhang L
    Eur J Pharmacol; 2020 Mar; 871():172927. PubMed ID: 31962101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
    Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR.
    Wang R; Li S; Chen P; Yue X; Wang S; Gu Y; Yuan Y
    Phytomedicine; 2022 Dec; 107():154435. PubMed ID: 36155216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of hepatic stellate cell activation and liver fibrosis by microRNA-33a-5p through targeting the Dickkopf-1-mediated wingless-related integration site/beta-catenin pathway.
    Liu H; Zhang S; Li Z; Zheng Z; Shi W; Hu M; Liu F
    J Physiol Pharmacol; 2023 Aug; 74(4):. PubMed ID: 37865960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.